Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (3,4-dimethoxyphenethylaminomethyl)-4-hydroxybenzyl Alcohol
2. 1-(p-hydroxyphenyl)-2-((3,4-dimethoxyphenethyl)amino)ethanol
3. Ta 064
4. Ta-064
1. 71771-90-9
2. R(-)-denopamine
3. Kalgut
4. Ta 064
5. Ta-064
6. 4-[(1r)-2-[2-(3,4-dimethoxyphenyl)ethylamino]-1-hydroxyethyl]phenol
7. V5f60upd8p
8. Chembl493682
9. Denopamina
10. Denopaminum
11. 4-[(1r)-2-[2-(3,4-dimethoxyphenyl)ethylamino]-1-hydroxy-ethyl]phenol
12. Benzenemethanol, A-[[[2-(3,4-dimethoxyphenyl)ethyl]amino]methyl]-4-hydroxy-,(ar)-
13. Denopaminum [latin]
14. Kalgut (tn)
15. Denopamina [spanish]
16. Denopamine [inn:jan]
17. Unii-v5f60upd8p
18. R()-denopamine
19. Ncgc00094384-01
20. Denopamine [mi]
21. Denopamine (jan/inn)
22. Denopamine [inn]
23. Denopamine [jan]
24. Lopac-d-7815
25. Denopamine [mart.]
26. Denopamine [who-dd]
27. Dsstox_cid_25800
28. Dsstox_rid_81138
29. Dsstox_gsid_45800
30. Gtpl534
31. Schembl218640
32. Dtxsid8045800
33. Chebi:135359
34. Bcp17423
35. Zinc1552175
36. Tox21_111272
37. Bdbm50252956
38. (-)-(r)-1-(p-hydroxyphenyl)-2-((3,4-dimethoxyphenethyl)amino)ethanol
39. Benzenemethanol, Alpha-(((2-(3,4-dimethoxyphenyl)ethyl)amino)methyl)-4-hydroxy-, (r)-
40. Ncgc00015367-01
41. Cas-71771-90-9
42. Hy-119515
43. Cs-0068617
44. R(-)-denopamine, >=98% (hplc), Powder
45. D02614
46. Dimethoxyphenyl)ethylamino]-1-hydroxyethyl]phenol
47. (r)-4-(2-(3,4-dimethoxyphenethylamino)-1-hydroxyethyl)phenol
48. 4-[(1r)-2-[2-(3,4-
49. 4-[(1r)-2-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-1-hydroxyethyl]phenol
50. (-)-(r)-.alpha.-(((3,4-dimethoxyphenethyl)amino)methyl)-p-hydroxybenzyl Alcohol
51. (-)-(r)-alpha-(((3,4-dimethoxyphenethyl)amino)methyl)-p-hydroxybenzyl Alcohol
| Molecular Weight | 317.4 g/mol |
|---|---|
| Molecular Formula | C18H23NO4 |
| XLogP3 | 1.8 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 8 |
| Exact Mass | 317.16270821 g/mol |
| Monoisotopic Mass | 317.16270821 g/mol |
| Topological Polar Surface Area | 71 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 320 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Cardiotonic Agents
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)
Adrenergic beta-Agonists
Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)
Market Place
ABOUT THIS PAGE
A Denopamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Denopamine, including repackagers and relabelers. The FDA regulates Denopamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Denopamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Denopamine supplier is an individual or a company that provides Denopamine active pharmaceutical ingredient (API) or Denopamine finished formulations upon request. The Denopamine suppliers may include Denopamine API manufacturers, exporters, distributors and traders.
click here to find a list of Denopamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Denopamine Drug Master File in Japan (Denopamine JDMF) empowers Denopamine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Denopamine JDMF during the approval evaluation for pharmaceutical products. At the time of Denopamine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Denopamine suppliers with JDMF on PharmaCompass.
Denopamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Denopamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Denopamine GMP manufacturer or Denopamine GMP API supplier for your needs.
A Denopamine CoA (Certificate of Analysis) is a formal document that attests to Denopamine's compliance with Denopamine specifications and serves as a tool for batch-level quality control.
Denopamine CoA mostly includes findings from lab analyses of a specific batch. For each Denopamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Denopamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Denopamine EP), Denopamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Denopamine USP).
LOOKING FOR A SUPPLIER?
